Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Carcinoma Metastatic in the Bone”

117 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 117 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05924672
What this trial is testing

Efficacy of Ra-223 in PSMA PET Optimally Selected Patients

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneStage IVB Prostate Cancer AJCC v8
University of California, San Francisco 2
Testing effectiveness (Phase 2)Ended earlyNCT04754425
What this trial is testing

Erdafitinib for the Treatment of Patients With Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaCastration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted AgentsMetastatic Malignant Neoplasm in the Bone+5 more
M.D. Anderson Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT00554918
What this trial is testing

Docetaxel and Prednisolone With or Without Zoledronic Acid and/or Strontium Chloride Sr 89 in Treating Patients With Prostate Cancer Metastatic to Bone That Has Not Responded to Hormone Therapy

Who this might be right for
Metastatic CancerProstate Cancer
University Hospital Birmingham 300
Testing effectiveness (Phase 2)Ended earlyNCT01703065
What this trial is testing

Cabozantinib in Men With Castration-Resistant Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateCastration-resistant Prostate CancerRecurrent Prostate Cancer+2 more
University of Washington 9
Not applicableStudy completedNCT04681144
What this trial is testing

Learn More About How Radium-223 Affects the Quality of Life of Colombian Patients With Prostate Cancer That Has Not Responded to Testosterone Lowering Treatment and Has Spread to the Bones, and to Better Understand Its Safety

Who this might be right for
Prostate Cancer
Bayer 103
Testing effectiveness (Phase 2)Study completedNCT02601014
What this trial is testing

Biomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Expressing AR-V7

Who this might be right for
Prostate CancerRecurrent Prostate CarcinomaStage IV Prostate Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 32
Testing effectiveness (Phase 2)Ended earlyNCT04616547
What this trial is testing

Treatment of Cancer-Related Bone Pain by Using Bone-Targeted Radiation-Based Therapy (Sn-117m-DTPA) in Patients With Prostate Cancer That Has Spread to Bones

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Prostate Adenocarcinoma+3 more
National Cancer Institute (NCI) 1
Large-scale testing (Phase 3)Study completedNCT00003884
What this trial is testing

Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone

Who this might be right for
Hypercalcemia of MalignancyLung CancerMetastatic Cancer+2 more
Novartis 600
Testing effectiveness (Phase 2)Study completedNCT00936975
What this trial is testing

Fluorine F 18 Sodium Fluoride Positron Emission Tomography in Evaluating Response to Dasatinib in Patients With Prostate Cancer and Bone Metastases

Who this might be right for
Hormone-Resistant Prostate CancerMetastatic Malignant Neoplasm in the BoneRecurrent Prostate Carcinoma+1 more
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)WithdrawnNCT02420587
What this trial is testing

AMG 208 Tumor Microenvironment in Metastatic Castration Resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01085565
What this trial is testing

Focused Ultrasound Surgery in the Treatment of Pain Resulting From Metastatic Bone Tumors With the ExAblate 2100 Conformal Bone System

Who this might be right for
Bone CancerBone MetastasesPain
InSightec 50
Testing effectiveness (Phase 2)Ended earlyNCT02215161
What this trial is testing

Selinexor in Treating Patients With Abiraterone Acetate and/or Enzalutamide Refractory Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneHormone-Resistant Prostate CancerMetastatic Prostate Carcinoma in the Soft Tissue+3 more
University of California, San Francisco 14
Early research (Phase 1)Study completedNCT00014456
What this trial is testing

Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors

Who this might be right for
Bladder CancerBreast CancerCarcinoma of Unknown Primary+9 more
Dartmouth-Hitchcock Medical Center 35
Early research (Phase 1)Study completedNCT00004065
What this trial is testing

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02384382
What this trial is testing

A Positron Emission Tomography/Computed Tomography (PET/CT) Bone Imaging Study in Patients Receiving Enzalutamide for Castration-Resistant Prostate Cancer (CRPC)

Who this might be right for
Prostate Carcinoma Metastatic to the BoneCastration Resistant Prostate Cancer
Pfizer 23
Large-scale testing (Phase 3)Study completedNCT00134056
What this trial is testing

S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy

Who this might be right for
Metastatic CancerProstate Cancer
SWOG Cancer Research Network 1,038
Not applicableEnded earlyNCT05301062
What this trial is testing

A Research Called CREDIT Studies How Safe the Study Treatment Radium-223 is and How Well it Works in Chinese Men With Advanced Prostate Cancer That Has Spread to the Bones and Does Not Respond to Treatments for Lowering Testosterone Levels

Who this might be right for
Metastatic Castration-resistant Prostate CancerBone Metastases
Bayer 8
Testing effectiveness (Phase 2)Looking for participantsNCT07292168
What this trial is testing

A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Expressing Fibroblast Growth Factor Receptor 1

Who this might be right for
Renal Cell Carcinoma MetastaticProstate Cancer MetastaticNon-small Cell Lung Cancer Metastatic+2 more
Kidney Cancer Research Bureau 58
Not applicableUnknownNCT03134261
What this trial is testing

Diagnostic Imaging of Bone Metastases in Prostate Cancer Patients

Who this might be right for
Prostate Cancer Metastatic to Bone
Herlev Hospital 300
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Load More Results